retatrutide effects clinical trial retatrutide Weight Loss Treatment Explained Reta clinical trial data &

Dual GIP and GLP-1 receptor agonist Tirzepatide improves beta-cell function and insulin sensitivity in type 2 diabetes

Those with cardiovascular disease, kidney disease, or other chronic conditions may have specific dietary requirements that affect calorie distribution and total intake

Though Retatrutide is not yet FDA-approved, its potential effectiveness shows great promise, as evidenced by the TRIUMPH-1 Phase 3 trials that demonstrated up to 28.3% weight loss over 80 weeks

However, many of those who could benefit from these drugs are in lower income households and with the monthly cost as high as $1k without coverage, these drugs are out of reach for many who need it

Your healthcare provider can help you decide which drug may be a fit for you

You pay for your care directly